Amundi Cellebrite Di Ltd. Transaction History
Amundi
- $264 Billion
- Q3 2024
A detailed history of Amundi transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Amundi holds 5,116 shares of CLBT stock, worth $90,553. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,116
Previous 9,423
45.71%
Holding current value
$90,553
Previous $112,000
23.21%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CLBT
# of Institutions
175Shares Held
108MCall Options Held
741KPut Options Held
205K-
Igp Investments (G.P.L.P), LP Herzliya, L321.1MShares$373 Million95.53% of portfolio
-
True Wind Capital Management, L.P.11.7MShares$208 Million81.05% of portfolio
-
Morgan Stanley New York, NY5.38MShares$95.1 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA4.39MShares$77.7 Million0.23% of portfolio
-
Nine Ten Capital Management LLC Evanston, IL4.33MShares$76.6 Million22.02% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.36B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...